Published in PLoS Biol on March 30, 2010
Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol (2010) 27.58
A call for transparent reporting to optimize the predictive value of preclinical research. Nature (2012) 14.63
Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci (2013) 13.37
Can animal models of disease reliably inform human studies? PLoS Med (2010) 6.27
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol (2015) 5.57
Increasing value and reducing waste: addressing inaccessible research. Lancet (2014) 4.83
The Economics of Reproducibility in Preclinical Research. PLoS Biol (2015) 4.68
Two years later: journals are not yet enforcing the ARRIVE guidelines on reporting standards for pre-clinical animal studies. PLoS Biol (2014) 3.17
Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration. PLoS Biol (2010) 2.72
Evaluation of excess significance bias in animal studies of neurological diseases. PLoS Biol (2013) 2.70
Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research. J Pharmacol Pharmacother (2010) 2.27
A search filter for increasing the retrieval of animal studies in Embase. Lab Anim (2011) 2.09
Threats to validity in the design and conduct of preclinical efficacy studies: a systematic review of guidelines for in vivo animal experiments. PLoS Med (2013) 1.92
Factors affecting the apparent efficacy and safety of tissue plasminogen activator in thrombotic occlusion models of stroke: systematic review and meta-analysis. J Cereb Blood Flow Metab (2010) 1.89
Therapeutic hypothermia for acute ischemic stroke: ready to start large randomized trials? J Cereb Blood Flow Metab (2010) 1.85
Publication and other reporting biases in cognitive sciences: detection, prevalence, and prevention. Trends Cogn Sci (2014) 1.69
Lost in translation: animal models and clinical trials in cancer treatment. Am J Transl Res (2014) 1.63
Tracking replicability as a method of post-publication open evaluation. Front Comput Neurosci (2012) 1.56
Predicting harms and benefits in translational trials: ethics, evidence, and uncertainty. PLoS Med (2011) 1.52
Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studies. Alzheimers Res Ther (2011) 1.43
Progress in using systematic reviews of animal studies to improve translational research. PLoS Med (2013) 1.34
Why animal research needs to improve. Nature (2011) 1.32
Big data from small data: data-sharing in the 'long tail' of neuroscience. Nat Neurosci (2014) 1.24
Publication bias in laboratory animal research: a survey on magnitude, drivers, consequences and potential solutions. PLoS One (2012) 1.23
The need for randomization in animal trials: an overview of systematic reviews. PLoS One (2014) 1.22
Knowledge integration in cancer: current landscape and future prospects. Cancer Epidemiol Biomarkers Prev (2012) 1.19
Fighting publication bias: introducing the Negative Results section. J Cereb Blood Flow Metab (2010) 1.17
Bringing rigour to translational medicine. Nat Rev Neurol (2013) 1.16
A step-by-step guide to systematically identify all relevant animal studies. Lab Anim (2011) 1.16
Distinguishing between exploratory and confirmatory preclinical research will improve translation. PLoS Biol (2014) 1.15
Enhancing credibility of chemical safety studies: emerging consensus on key assessment criteria. Environ Health Perspect (2010) 1.15
Inflammatory findings on species extrapolations: humans are definitely no 70-kg mice. Arch Toxicol (2013) 1.14
Should preclinical studies be registered? Nat Biotechnol (2012) 1.14
Where Have All the Rodents Gone? The Effects of Attrition in Experimental Research on Cancer and Stroke. PLoS Biol (2016) 1.14
Improving basic and translational science by accounting for litter-to-litter variation in animal models. BMC Neurosci (2013) 1.12
Systematic reviews and meta-analysis of preclinical studies: why perform them and how to appraise them critically. J Cereb Blood Flow Metab (2014) 1.11
Stem cell transplantation in traumatic spinal cord injury: a systematic review and meta-analysis of animal studies. PLoS Biol (2013) 1.10
Reporting animal studies: good science and a duty of care. PLoS Biol (2010) 1.07
Hyperglycaemia and infarct size in animal models of middle cerebral artery occlusion: systematic review and meta-analysis. J Cereb Blood Flow Metab (2010) 1.04
Look back in anger - what clinical studies tell us about preclinical work. ALTEX (2013) 1.04
Neuroprotection for stroke: current status and future perspectives. Int J Mol Sci (2012) 1.04
Neuroprotection after stroke by targeting NOX4 as a source of oxidative stress. Antioxid Redox Signal (2012) 1.03
Improving the translation of analgesic drugs to the clinic: animal models of neuropathic pain. Br J Pharmacol (2014) 1.03
Are Underlying Assumptions of Current Animal Models of Human Stroke Correct: from STAIRs to High Hurdles? Transl Stroke Res (2011) 1.01
Open science and reporting animal studies: who's accountable? PLoS Biol (2014) 1.01
Drug repurposing: a systematic approach to evaluate candidate oral neuroprotective interventions for secondary progressive multiple sclerosis. PLoS One (2015) 1.00
Methodological quality of preclinical stroke studies is not required for publication in high-impact journals. J Cereb Blood Flow Metab (2010) 0.98
Still cooling after all these years: Meta-analysis of pre-clinical trials of therapeutic hypothermia for acute ischemic stroke. J Cereb Blood Flow Metab (2016) 0.97
Why selective publication of statistically significant results can be effective. PLoS One (2013) 0.97
Fire in the ashes: can failed Alzheimer's disease drugs succeed with second chances? Alzheimers Dement (2012) 0.97
A critical appraisal of experimental intracerebral hemorrhage research. J Cereb Blood Flow Metab (2012) 0.97
Benefits of histone deacetylase inhibitors for acute brain injury: a systematic review of animal studies. J Neurochem (2010) 0.97
Evaluation of combination therapy in animal models of cerebral ischemia. J Cereb Blood Flow Metab (2012) 0.97
Frontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug development. Alzheimers Dement (2012) 0.96
Estimating Information Processing in a Memory System: The Utility of Meta-analytic Methods for Genetics. PLoS Genet (2015) 0.96
Can animal data predict human outcome? Problems and pitfalls of translational animal research. Eur J Nucl Med Mol Imaging (2012) 0.93
Endpoint measures in the mdx mouse relevant for muscular dystrophy pre-clinical studies. Neuromuscul Disord (2011) 0.92
Preclinical Efficacy Failure of Human CNS-Derived Stem Cells for Use in the Pathway Study of Cervical Spinal Cord Injury. Stem Cell Reports (2017) 0.91
Do stroke models model stroke? Dis Model Mech (2012) 0.91
Efficacy and safety of mesenchymal stromal cells in preclinical models of acute lung injury: a systematic review protocol. Syst Rev (2014) 0.91
Systematic review and stratified meta-analysis of the efficacy of RhoA and Rho kinase inhibitors in animal models of ischaemic stroke. Syst Rev (2013) 0.90
Assessing risk/benefit for trials using preclinical evidence: a proposal. J Med Ethics (2015) 0.90
Pharmacologic reduction of angiographic vasospasm in experimental subarachnoid hemorrhage: systematic review and meta-analysis. J Cereb Blood Flow Metab (2012) 0.89
The significance of meaning: why do over 90% of behavioral neuroscience results fail to translate to humans, and what can we do to fix it? ILAR J (2014) 0.88
Pharmacological intervention studies using mouse models of the inflammatory bowel diseases: translating preclinical data into new drug therapies. Inflamm Bowel Dis (2011) 0.87
Why publishing everything is more effective than selective publishing of statistically significant results. PLoS One (2014) 0.87
Managing risks in drug discovery: reproducibility of published findings. Naunyn Schmiedebergs Arch Pharmacol (2016) 0.87
The 1027th target candidate in stroke: Will NADPH oxidase hold up? Exp Transl Stroke Med (2012) 0.87
The usefulness of systematic reviews of animal experiments for the design of preclinical and clinical studies. ILAR J (2014) 0.87
Tissue-type plasminogen activator is a neuroprotectant in the central nervous system. Front Cell Neurosci (2015) 0.87
The use of systematic reviews and reporting guidelines to advance the implementation of the 3Rs. J Am Assoc Lab Anim Sci (2015) 0.86
You are what you eat, or are you? The challenges of translating high-fat-fed rodents to human obesity and diabetes. Nutr Diabetes (2014) 0.86
The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta-analyses. Milbank Q (2016) 0.86
A combined pre-clinical meta-analysis and randomized confirmatory trial approach to improve data validity for therapeutic target validation. Sci Rep (2015) 0.86
Meta-analyses of animal studies: an introduction of a valuable instrument to further improve healthcare. ILAR J (2014) 0.85
Reporting of preclinical tumor-graft cancer therapeutic studies. Cancer Biol Ther (2012) 0.85
Neuroprotective Strategies after Neonatal Hypoxic Ischemic Encephalopathy. Int J Mol Sci (2015) 0.84
The evolution of traumatic brain injury in a rat focal contusion model. NMR Biomed (2012) 0.84
Systematic review and meta-analysis of therapeutic hypothermia in animal models of spinal cord injury. PLoS One (2013) 0.84
Cannabinoids in experimental stroke: a systematic review and meta-analysis. J Cereb Blood Flow Metab (2014) 0.83
A preclinical physiological assay to test modulation of knee joint pain in the spinal cord: effects of oxycodone and naproxen. PLoS One (2014) 0.82
Conflict of interest in spine research reporting. PLoS One (2012) 0.82
Authorization of Animal Experiments Is Based on Confidence Rather than Evidence of Scientific Rigor. PLoS Biol (2016) 0.82
Introducing Therioepistemology: the study of how knowledge is gained from animal research. Lab Anim (NY) (2017) 0.82
Assessing the application of the 3Rs: a survey among animal welfare officers in The Netherlands. Lab Anim (2013) 0.81
The relationship between study sponsorship, risks of bias, and research outcomes in atrazine exposure studies conducted in non-human animals: Systematic review and meta-analysis. Environ Int (2015) 0.81
The institutional review board is an impediment to human research: the result is more animal-based research. Philos Ethics Humanit Med (2011) 0.81
Therapeutics targeting Nogo-A hold promise for stroke restoration. CNS Neurol Disord Drug Targets (2013) 0.80
Use of Humanized Mice to Study the Pathogenesis of Autoimmune and Inflammatory Diseases. Inflamm Bowel Dis (2015) 0.80
Animal welfare in studies on murine tuberculosis: assessing progress over a 12-year period and the need for further improvement. PLoS One (2012) 0.80
The multifactorial role of the 3Rs in shifting the harm-benefit analysis in animal models of disease. Eur J Pharmacol (2015) 0.80
Pain and Laboratory Animals: Publication Practices for Better Data Reproducibility and Better Animal Welfare. PLoS One (2016) 0.79
Remote ischaemic conditioning reduces infarct size in animal in vivo models of ischaemia-reperfusion injury: a systematic review and meta-analysis. Cardiovasc Res (2016) 0.79
Year in review 2013: Critical Care--respirology. Crit Care (2014) 0.79
Hypothermia protects human neurons. Int J Stroke (2014) 0.79
Embracing Biological and Methodological Variance in a New Approach to Pre-Clinical Stroke Testing. Transl Stroke Res (2016) 0.79
Industry sponsorship and publication bias among animal studies evaluating the effects of statins on atherosclerosis and bone outcomes: a meta-analysis. BMC Med Res Methodol (2015) 0.78
Anesthetic Neuroprotection in Experimental Stroke in Rodents: A Systematic Review and Meta-analysis. Anesthesiology (2017) 0.78
The Validity of Conscientiousness Is Overestimated in the Prediction of Job Performance. PLoS One (2015) 0.78
Animal models of neurological disorders. Neurotherapeutics (2012) 0.78
Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24
Why most published research findings are false. PLoS Med (2005) 41.68
A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. JAMA (1992) 22.27
Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ (2001) 20.65
Clinical trial registration: a statement from the International Committee of Medical Journal Editors. N Engl J Med (2004) 14.78
The case of the misleading funnel plot. BMJ (2006) 8.26
Where is the evidence that animal research benefits humans? BMJ (2004) 5.99
Comparison of treatment effects between animal experiments and clinical trials: systematic review. BMJ (2006) 5.05
Pooling of animal experimental data reveals influence of study design and publication bias. Stroke (2004) 4.37
The science of reviewing research. Ann N Y Acad Sci (1993) 4.15
Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality. Stroke (2008) 3.87
How can we improve the pre-clinical development of drugs for stroke? Trends Neurosci (2007) 3.67
How citation distortions create unfounded authority: analysis of a citation network. BMJ (2009) 3.66
Good laboratory practice: preventing introduction of bias at the bench. Stroke (2008) 3.27
Systematic review and metaanalysis of the efficacy of FK506 in experimental stroke. J Cereb Blood Flow Metab (2005) 3.20
Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis. Brain (2007) 2.94
Methodological quality of systematic reviews of animal studies: a survey of reviews of basic research. BMC Med Res Methodol (2006) 2.23
Systematic review and stratified meta-analysis of the efficacy of interleukin-1 receptor antagonist in animal models of stroke. J Stroke Cerebrovasc Dis (2009) 2.12
Publication bias in ecology and evolution: an empirical assessment using the 'trim and fill' method. Biol Rev Camb Philos Soc (2002) 1.76
Effects of NXY-059 in experimental stroke: an individual animal meta-analysis. Br J Pharmacol (2009) 1.60
Estrogens and experimental ischemic stroke: a systematic review. J Cereb Blood Flow Metab (2006) 1.59
Publication bias in gastroenterological research - a retrospective cohort study based on abstracts submitted to a scientific meeting. BMC Med Res Methodol (2002) 1.46
A systematic review of nitric oxide donors and L-arginine in experimental stroke; effects on infarct size and cerebral blood flow. Nitric Oxide (2005) 1.36
Systematic review and meta-analysis of the efficacy of melatonin in experimental stroke. J Pineal Res (2005) 1.35
Nitric oxide synthase inhibitors in experimental ischemic stroke and their effects on infarct size and cerebral blood flow: a systematic review. Free Radic Biol Med (2005) 1.34
Systematic review and meta-analysis of the efficacy of tirilazad in experimental stroke. Stroke (2007) 1.22
A systematic review and meta-analysis of the efficacy of piracetam and piracetam-like compounds in experimental stroke. Cerebrovasc Dis (2007) 1.13
Inhibition of nitric oxide synthesis does not reduce infarct volume in a rat model of focal cerebral ischaemia. Neurosci Lett (1992) 0.98
Up from 'false positives' in genetic-and other-epidemiology. Eur J Epidemiol (2008) 0.97
L-arginine does not improve cortical perfusion or histopathological outcome in spontaneously hypertensive rats subjected to distal middle cerebral artery photothrombotic occlusion. J Cereb Blood Flow Metab (1996) 0.97
Effects of chronic overexpression of interleukin-1 receptor antagonist in a model of permanent focal cerebral ischemia in mouse. Acta Neuropathol (2004) 0.91
Influence of a 'brain protector' drug 21-amino steroid on the effects of experimental embolic stroke treated by thrombolysis. Neurol Res (1995) 0.91
Evaluation of recombinant human basic fibroblast growth factor (rhbFGF) as a cerebroprotective agent using high speed MR imaging. Brain Res (1995) 0.88
A call for transparent reporting to optimize the predictive value of preclinical research. Nature (2012) 14.63
1,026 experimental treatments in acute stroke. Ann Neurol (2006) 7.23
Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke (2009) 6.79
Can animal models of disease reliably inform human studies? PLoS Med (2010) 6.27
Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol (2007) 6.15
The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet (2011) 5.17
Pooling of animal experimental data reveals influence of study design and publication bias. Stroke (2004) 4.37
Blood pressure and clinical outcomes in the International Stroke Trial. Stroke (2002) 3.94
Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol (2009) 3.89
Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality. Stroke (2008) 3.87
How can we improve the pre-clinical development of drugs for stroke? Trends Neurosci (2007) 3.67
Early dual versus mono antiplatelet therapy for acute non-cardioembolic ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis. Circulation (2013) 3.57
Treatment of brain arteriovenous malformations: a systematic review and meta-analysis. JAMA (2011) 3.40
New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the International Carotid Stenting Study (ICSS). Lancet Neurol (2010) 3.35
Good laboratory practice: preventing introduction of bias at the bench. Stroke (2008) 3.27
Predicting long-term outcome after acute ischemic stroke: a simple index works in patients from controlled clinical trials. Stroke (2008) 3.21
Systematic review and metaanalysis of the efficacy of FK506 in experimental stroke. J Cereb Blood Flow Metab (2005) 3.20
Empirical evidence of bias in the design of experimental stroke studies: a metaepidemiologic approach. Stroke (2008) 2.98
Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis. Brain (2007) 2.94
Can we improve the statistical analysis of stroke trials? Statistical reanalysis of functional outcomes in stroke trials. Stroke (2007) 2.86
The Paracetamol (Acetaminophen) In Stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trial. Lancet Neurol (2009) 2.78
Improving the translational hit of experimental treatments in multiple sclerosis. Mult Scler (2010) 2.73
Evaluation of excess significance bias in animal studies of neurological diseases. PLoS Biol (2013) 2.70
High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension (2003) 2.52
Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis. Eur Heart J (2008) 2.36
Treatment of space-occupying cerebral infarction. Crit Care Med (2003) 2.14
Systematic review and stratified meta-analysis of the efficacy of interleukin-1 receptor antagonist in animal models of stroke. J Stroke Cerebrovasc Dis (2009) 2.12
Therapeutic hypothermia and the risk of infection: a systematic review and meta-analysis. Crit Care Med (2014) 2.05
Predicting clinical outcomes after thrombolysis using the iScore: results from the Virtual International Stroke Trials Archive. Stroke (2013) 2.01
Blood pressure measurement reliability among different racial-ethnic groups in a stroke prevention study. Blood Press Monit (2014) 1.97
Factors affecting the apparent efficacy and safety of tissue plasminogen activator in thrombotic occlusion models of stroke: systematic review and meta-analysis. J Cereb Blood Flow Metab (2010) 1.89
COL4A1 mutation in two preterm siblings with antenatal onset of parenchymal hemorrhage. Ann Neurol (2009) 1.87
Therapeutic hypothermia for acute ischemic stroke: ready to start large randomized trials? J Cereb Blood Flow Metab (2010) 1.85
Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials. Stroke (2004) 1.69
Dopamine agonists in animal models of Parkinson's disease: a systematic review and meta-analysis. Parkinsonism Relat Disord (2011) 1.64
Impact of resting heart rate on mortality, disability and cognitive decline in patients after ischaemic stroke. Eur Heart J (2012) 1.62
Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials. Lancet Neurol (2013) 1.62
Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension (2006) 1.61
Relation between change in blood pressure in acute stroke and risk of early adverse events and poor outcome. Stroke (2012) 1.60
Estrogens and experimental ischemic stroke: a systematic review. J Cereb Blood Flow Metab (2006) 1.59
Relationship between outcome and baseline blood pressure and other haemodynamic measures in acute ischaemic stroke: data from the TAIST trial. J Hypertens (2006) 1.58
Progesterone for the treatment of experimental brain injury; a systematic review. Brain (2007) 1.54
Reprint: Good laboratory practice: preventing introduction of bias at the bench. J Cereb Blood Flow Metab (2008) 1.47
G-CSF reduces infarct volume and improves functional outcome after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab (2005) 1.46
A systematic review and meta-analysis of erythropoietin in experimental stroke. J Cereb Blood Flow Metab (2009) 1.45
Balance of symptomatic pulmonary embolism and symptomatic intracerebral hemorrhage with low-dose anticoagulation in recent ischemic stroke: a systematic review and meta-analysis of randomized controlled trials. J Stroke Cerebrovasc Dis (2012) 1.43
Contemporary outcome measures in acute stroke research: choice of primary outcome measure. Stroke (2012) 1.43
A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND). Int J Stroke (2012) 1.42
Effect of the neutral CLOTS 1 trial on the use of graduated compression stockings in the Efficacy of Nitric Oxide Stroke (ENOS) trial. J Neurol Neurosurg Psychiatry (2012) 1.42
Different strokes for different folks: the rich diversity of animal models of focal cerebral ischemia. J Cereb Blood Flow Metab (2010) 1.42
Modification of the method of thread manufacture improves stroke induction rate and reduces mortality after thread-occlusion of the middle cerebral artery in young or aged rats. J Neurosci Methods (2006) 1.41
Inflammation following stroke. J Clin Neurosci (2006) 1.40
Surveying the literature from animal experiments: systematic review and meta-analysis are important contributions. BMJ (2005) 1.38
A systematic review of nitric oxide donors and L-arginine in experimental stroke; effects on infarct size and cerebral blood flow. Nitric Oxide (2005) 1.36
Systematic review and meta-analysis of the efficacy of melatonin in experimental stroke. J Pineal Res (2005) 1.35
Systematic survey of the design, statistical analysis, and reporting of studies published in the 2008 volume of the Journal of Cerebral Blood Flow and Metabolism. J Cereb Blood Flow Metab (2010) 1.35
The Virtual International Stroke Trials Archive. Stroke (2007) 1.34
Relationship between therapeutic changes in blood pressure and outcomes in acute stroke: a metaregression. Hypertension (2009) 1.30
Sex differences in quality of life in stroke survivors: data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST). Stroke (2007) 1.29
Interventions for dysphagia and nutritional support in acute and subacute stroke. Cochrane Database Syst Rev (2012) 1.26
Treatment of intracerebral hemorrhage in animal models: meta-analysis. Ann Neurol (2011) 1.26
G-CSF suppresses edema formation and reduces interleukin-1beta expression after cerebral ischemia in mice. J Neuropathol Exp Neurol (2005) 1.25
An early rise in body temperature is related to unfavorable outcome after stroke: data from the PAIS study. J Neurol (2010) 1.25
Sample size calculations in acute stroke trials: a systematic review of their reporting, characteristics, and relationship with outcome. Stroke (2004) 1.22
PAIS: paracetamol (acetaminophen) in stroke; protocol for a randomized, double blind clinical trial [ISCRTN 74418480]. BMC Cardiovasc Disord (2005) 1.22
Animal models of bone cancer pain: systematic review and meta-analyses. Pain (2013) 1.22
How to make better use of thrombolytic therapy in acute ischemic stroke. Nat Rev Neurol (2011) 1.22
Progesterone suppresses the inflammatory response and nitric oxide synthase-2 expression following cerebral ischemia. Exp Neurol (2005) 1.19
Should stroke trials adjust functional outcome for baseline prognostic factors? Stroke (2009) 1.19
Granulocyte-colony stimulating factor in experimental stroke and its effects on infarct size and functional outcome: A systematic review. Brain Res Rev (2009) 1.18
Stroke research at a road block: the streets from adversity should be paved with meta-analysis and good laboratory practice. Br J Pharmacol (2009) 1.18
EuroHYP-1: European multicenter, randomized, phase III clinical trial of therapeutic hypothermia plus best medical treatment vs. best medical treatment alone for acute ischemic stroke. Int J Stroke (2014) 1.13
A systematic review and meta-analysis of the efficacy of piracetam and piracetam-like compounds in experimental stroke. Cerebrovasc Dis (2007) 1.13
Greater incidence of both fatal and nonfatal strokes in disadvantaged areas: the Northeast Melbourne Stroke Incidence Study. Stroke (2006) 1.13
Contribution of the left and right inferior frontal gyrus in recovery from aphasia. A functional MRI study in stroke patients with preserved hemodynamic responsiveness. Neuroimage (2009) 1.13
Preclinical studies of human disease: time to take methodological quality seriously. J Mol Cell Cardiol (2011) 1.13
Stem cell-based therapy for experimental stroke: a systematic review and meta-analysis. Int J Stroke (2012) 1.11